Evidence map›Paper›PMID 30903933›Full record

ArticleCancer treatment and research communications2019

Hepatocellular carcinoma: Clinical-pathological features and HIV infection in Mozambican patients<sup/>.

Lina Cunha, Carla Carrilho, Nilesh Bhatt, Michella Loforte, Cremildo Maueia, Fabíola Fernandes, Assucena Guisseve, Francisco Mbofana, Fatima Maibaze, Liana Mondlane and 7 more

Open access · greenAbstract read
In one paragraph

Article in Cancer treatment and research communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 4 countries.

Lina CunhaGastroenterology Service, Maputo Private Hospital, Maputo, Rua do Rio Inhamiara-Sommerchield II-Maputo, Mozambique. Electronic address: linabcunha@gmail.com.
Carla CarrilhoDepartment of Pathology, Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique; Department of Pathology - Maputo Central Hospital, Maputo, Mozambique.
Nilesh BhattNational Institute of Health, Maputo, Mozambique.
Michella LoforteDepartment of Medicine, Gastroenterology Service, Maputo Central Hospital, Maputo, Mozambique.
Cremildo MaueiaNational Institute of Health, Maputo, Mozambique.
Fabíola FernandesDepartment of Pathology, Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique; Department of Pathology - Maputo Central Hospital, Maputo, Mozambique.
Assucena GuisseveDepartment of Pathology, Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique; Department of Pathology - Maputo Central Hospital, Maputo, Mozambique.
Francisco MbofanaNational AIDS Council, Maputo, Mozambique.
Fatima MaibazeDepartment of Medicine, Gastroenterology Service, Maputo Central Hospital, Maputo, Mozambique.
Liana MondlaneDepartment of Medicine, Gastroenterology Service, Maputo Central Hospital, Maputo, Mozambique.
Muhammad IsmailDepartment of Medicine, Gastroenterology Service, Maputo Central Hospital, Maputo, Mozambique.
Luzmira DimandeDepartment of Medicine, Gastroenterology Service, Maputo Central Hospital, Maputo, Mozambique.
Sheila MachatineDepartment of Medicine, Gastroenterology Service, Maputo Central Hospital, Maputo, Mozambique.
Nuno LunetEPIUnit - Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal.
Yu-Tsueng LiuUniversity of California San Diego, La Jolla, CA, United States.
Eduardo Samo GudoNational Institute of Health, Maputo, Mozambique.
Pascal PineauUnité « Organisation Nucléaire et Oncogenèse », INSERM U993, Institut Pasteur, Paris, France.
Maputo Central Hospital · MZEduardo Mondlane University · MZi3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto · PTInserm · FRUniversity of California San Diego · US

Funding

VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jesse Nodora · 1985 to 2026
$124.9M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI David Mitchell Smith · 1994 to 2026
$78.4M
The University Eduardo Mondlane/UCSD Health-Professional Education Partnership InitiativeR25TW011216 · FIC · EDUARDO MONDLANE UNIVERSITY · PI NOORMAHOMED, EMILIA VIRGINIA · 2018 to 2022
$3.2M
Enhanced Advanced Biomedical Research Training for MozambiqueD43TW010135 · FIC · EDUARDO MONDLANE UNIVERSITY · PI NOORMAHOMED, EMILIA VIRGINIA · 2015 to 2019
$3.2M
FIC NIH HHS D43 TW010135FIC NIH HHS R25 TW011216NCI NIH HHS P30 CA023100NIAID NIH HHS P30 AI036214
6 · The paper itself

Abstract

BACKGROUND AND

aimsMozambique had been ranked among the countries with the highest global incidence of HCC with chronic hepatitis B infection and high exposure to aflatoxin-B1 (AFB1) being major risk factors. Indeed, HCC remains one of the most frequent cancer in Maputo. On the other hand, Mozambique has a high prevalence of infection with Human Immunodeficiency virus (HIV). Our study aims to describe the epidemiology, clinicopathological and serological features of patients with HCC in Maputo Central Hospital and its relationship with HIV.

methodsA series of 206 patients, diagnosed with HCC via fine needle aspiration, were consecutively included in the study. Patient data was collected using a questionnaire and all patients were tested for HBV, HCV, HIV.

resultsMedian age was 49 years old and the M: F sex ratio was 2.4. A total of 114 (56.2%) of the patients were HBsAg positive. Hepatitis C antibodies were present in 8.9% of cases, and co-infection with HBV and HCV (HBsAg/anti-HCV) was observed in 4 (2.0%) cases. The remainder, 36.3%, were neither hepatitis B- nor C-related. HIV was detected in 34 cases (18.0%) cases. HIV-HBV or HIV-HCV co-infections were observed in 22 (68.8%) and 2 (6.2%) cases. Overall, positivity for HIV was associated with younger age, and especially in patients with HBsAg+/anti-HCV+.

conclusionsOur data emphasize the need for a reinforcement of secondary prevention measures in Mozambique. Serological screening for HBV in people born before universal anti-hepatitis B immunization (2001), effective screening, and specific management in HIV(+) patients are urgently needed.

Indexed as

AdultAgedCarcinoma, HepatocellularCoinfectionFemaleFollow-Up StudiesHepacivirusHepatitis BHepatitis B virusHepatitis CHIVHIV InfectionsHumansLiver NeoplasmsMaleMiddle AgedAbbreviations: HCC, hepatocellular carcinomaAFB1, Aflatoxin B1AFP, Alpha-fetoprotein.HBVHBV, hepatitis B virusHCV, hepatitis C virusHepatocellular carcinomaHIVHIV, human immunodeficiency virusMozambique

Identifiers

PMID30903933
PMCPMC6504939
OpenAlexW2921169214

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.